Fulton Breakefield Broenniman’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $233K | Sell |
796
-29
| -4% | -$9.53K | 0.02% | 180 |
|
|
2025
Q4 | $289K | Buy |
825
+29
| +4% | +$9.8K | 0.02% | 164 |
|
|
2025
Q3 | $257K | Sell |
796
-18
| -2% | -$5.6K | 0.02% | 177 |
|
|
2025
Q2 | $317K | Buy |
814
+18
| +2% | +$7.24K | 0.02% | 154 |
|
|
2025
Q1 | $346K | Hold |
796
| – | – | 0.03% | 134 |
|
|
2024
Q4 | $294K | Hold |
796
| – | – | 0.02% | 148 |
|
|
2024
Q3 | $414K | Hold |
796
| – | – | 0.03% | 124 |
|
|
2024
Q2 | $431K | Hold |
796
| – | – | 0.03% | 124 |
|
|
2024
Q1 | $413K | Hold |
796
| – | – | 0.03% | 121 |
|
|
2023
Q4 | $375K | Buy |
796
+78
| +11% | +$36.1K | 0.03% | 125 |
|
|
2023
Q3 | $313K | Buy |
718
+3
| +0.4% | +$1.36K | 0.03% | 137 |
|
|
2023
Q2 | $318K | Sell |
715
-3
| -0.4% | -$1.38K | 0.03% | 140 |
|
|
2023
Q1 | $330K | Buy |
718
+3
| +0.4% | +$1.43K | 0.03% | 136 |
|
|
2022
Q4 | $367K | Hold |
715
| – | – | 0.03% | 131 |
|
|
2022
Q3 | $325K | Hold |
715
| – | – | 0.03% | 131 |
|
|
2022
Q2 | $345K | Buy |
+715
| New | +$354K | 0.03% | 132 |
|
|
2022
Q1 | – | Sell |
-711
| Closed | -$330K | – | 176 |
|
|
2021
Q4 | $330K | Hold |
711
| – | – | 0.02% | 164 |
|
|
2021
Q3 | $265K | Hold |
711
| – | – | 0.02% | 158 |
|
|
2021
Q2 | $271K | Hold |
711
| – | – | 0.02% | 162 |
|
|
2021
Q1 | $255K | Hold |
711
| – | – | 0.02% | 160 |
|
|
2020
Q4 | $228K | Buy |
+711
| New | +$218K | 0.03% | 129 |
|
|
2020
Q1 | – | Sell |
-711
| Closed | -$215K | – | 162 |
|
|
2019
Q4 | $215K | Buy |
+711
| New | +$196K | 0.03% | 177 |
|
|
2015
Q2 | – | Sell |
-29,830
| Closed | -$4.61M | – | 124 |
|
|
2015
Q1 | $4.61M | Buy |
29,830
+147
| +0.5% | +$20.9K | 1.03% | 42 |
|
|
2014
Q4 | $3.73M | Buy |
29,683
+218
| +0.7% | +$26.9K | 0.82% | 50 |
|
|
2014
Q3 | $3.52M | Buy |
29,465
+460
| +2% | +$52.8K | 0.83% | 53 |
|
|
2014
Q2 | $3.12M | Sell |
29,005
-219
| -0.7% | -$22.6K | 0.76% | 53 |
|
|
2014
Q1 | $2.91M | Sell |
29,224
-103
| -0.4% | -$9.32K | 0.75% | 52 |
|
|
2013
Q4 | $2.71M | Sell |
29,327
-600
| -2% | -$53.3K | 0.72% | 55 |
|
|
2013
Q3 | $2.5M | Buy |
29,927
+1,236
| +4% | +$106K | 0.67% | 55 |
|
|
2013
Q2 | $2.35M | Buy |
+28,691
| New | +$2.15M | 0.69% | 55 |
|
Other funds holding ELV
VCM
VPM
Fulton Breakefield Broenniman's ELV Position: Q1 2026 in Review
Fulton Breakefield Broenniman reduced its Elevance Health (ELV) stake by 3.5% in Q1 2026, selling an estimated $9.53K and leaving 796 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #180.
Fulton Breakefield Broenniman first reported a position in ELV in Q2 2013 and has held it in 30 quarters since. The position peaked at $4.61M in Q1 2015. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Fulton Breakefield Broenniman held 796 shares of Elevance Health worth $233K as of Q1 2026.
- Fulton Breakefield Broenniman sold 29 Elevance Health shares in Q1 2026, an estimated $9.53K.
- Elevance Health made up 0.02% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #180 holding.
- Fulton Breakefield Broenniman first reported a position in Elevance Health in Q2 2013 and has held it in 30 quarters since.
- Fulton Breakefield Broenniman's Elevance Health position peaked at $4.61M in Q1 2015.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.